Evaluation of Clinical Efficacy of Metformin Therapy in Polycystic Ovary Syndrome
Abstract
Objective: To evaluate the metformin efficacy in Polycystic Ovary Syndrome (PCOS), intent to regulate the menstrual cycle and achieving pregnancy rate (live birth, stillbirth) in infertile women with PCOS proportions experiencing spontaneous abortion and time of pregnancy and investigation of the neonatal out comes. Methods: The cross sectional observational study was conducted between January 2012 and December 2014. Totally 310 patients with PCOS in the age group of 18 to 35 enrolled in the study and 220 patients with PCOS were included in the study. Evaluation included the collection of laboratory data, efficacy assessment of hirsutism, acne in PCOS and pre and post therapy of metformin in abortion rate, malformation and live birth rates. Result: Totally 101 subjects had a symptoms of acne and 117 subjects were had symptoms of hirsutism. Metformin therapy significantly reduced incidence of acne and hirsutism. Metformin therapy also significantly increased the number of conceptions from 112 to 138 and reduced abortion and malformation rates. Conclusion: This study has shown a consistent efficacy of metformin in PCOS of patients and improves the live birth rates. Thus, it demonstrates that the therapy of metformin was efficient and well tolerated, especially in teritoginicity and resumes the menstrual cyclicity and reduces the acne and hirsutism in PCOS patients. Key words: Acne, Hirsutism, Metformin, Pregnancy, Polycystic Ovary Syndrome.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.